"It's collective decision-making. You have several health care practitioners that know the patient and who bring different information to the table. And making a joint decision is better for the patient."
Behnam Badie, M.D., director, Brain Tumors Program
Getting treatment for pituitary gland disorders at City of Hope puts you at the center of some of the most innovative and groundbreaking research and surgical methods for brain tumors. Our neurosurgeons regularly treat difficult cases and use their expertise to design innovative, less invasive surgical approaches — including using fewer incisions to remove most of the tumor tissue to preserve patient functioning and quality of life.
Pituitary tumors, which start in the pituitary gland, are usually benign (noncancerous) and represent up to 20% of all primary brain tumors.
City of Hope conducts pituitary disorder clinical trials, which may be unavailable to the general public. Current research ranges from genetic testing to developing better imaging techniques to DNA-based growth hormone therapy.
When it comes to treatment for pituitary disorders, City of Hope has an unmatched reputation for comprehensive and compassionate care. Our team has pioneered state-of-the-art procedures that target tumor cells while minimizing side effects. We bring together broad expertise from multiple disciplines under one roof to provide exceptional care, including:
Advanced tests that detect pituitary disorders early, before they do serious harm
Minimally invasive surgery targets tumors while preserving healthy tissue
Unique surgical expertise removes tumors once considered inoperable
Radiation therapy, including ultraprecise helical TomoTherapy
Drug and hormone therapy to control irregular hormone production
Pioneering drug research and clinical trials
City of Hope’s team of neurosurgeons, endocrinologists, researchers, nurses, radiologists and genetic counselors work together closely at all stages of your care to provide seamless, coordinated care. We balance that approach with personalized medicine — not just when it comes to your condition, but the kind that makes you feel supported throughout your treatment. And our commitment to personalized care means preserving your quality of life is at the heart of your treatment.
City of Hope is one of the few facilities designated a comprehensive cancer center by the National Cancer Institute.
Duarte - Main Campus; Antelope Valley; South Pasadena; Upland
Clarke Anderson, M.D., is City of Hope's go-to professional for handling difficult and often heart-rending cases of cancer in small children, especially neuroblastomas, or tumors of the central nervous system.
A prolific researcher and talented surgeon, Mike Y. Chen, M.D., Ph.D, has been on City of Hope's neurosurgery team since 2007. He specializes in complex operations for the removal of brain and spine tumors.
Sasan Fazeli, M.D., is an endocrinologist in the Department of Diabetes, Endocrinology & Metabolism. Dr. Fazeli specializes in endocrinology with a special interest in the genetic profile of thyroid cancers, the latest adrenal and neuroendocrine tumor treatments, and advancements in the field of